Announcements Trials
Browse Landscape

Phase

Phase 2 223Phase 1 57Phase 3 48Phase 1/2 47Phase NA 18Phase EARLY_PHASE1 5Phase 2/3 3

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Non-Hodgkin 4Lymphoma, Follicular 3Lymphoma 3Recurrence 2Lymphoma, B-Cell 2Waldenstrom Macroglobulinemia 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia 1Immunoproliferative Disorders 1

Interventions

Cyclophosphamide 10Etoposide 6Doxorubicin 6Cytarabine 6Prednisone 5Vincristine 4Trimethoprim, Sulfamethoxazole Drug Combination 4Methotrexate 4gamma-Globulins 3Rituximab 3Radiotherapy 3Filgrastim 3Ciprofloxacin 3pegaspargase 2nelarabine 2etoposide phosphate 2calaspargase pegol 2Triptorelin Pamoate 2Thioguanine 2Prednisolone 2Methylprednisolone 2Mercaptopurine 2Melphalan 2Magnetic Resonance Spectroscopy 2Immunoglobulins, Intravenous 2Dexamethasone 2Daunorubicin 2Cyclosporine 2Calcium Dobesilate 2Bortezomib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Lymphoma × Rituximab × Clear all
NCT02405676 2026-03-19

BNHL-2015

Children's Cancer Group, China

Phase 2/3 Active not recruiting
200 enrolled
Lymphoid

Lymphoma

NCT01046825 2025-12-10

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT00641095 2018-10-31

MCLPIII

University College, London

Phase 2/3 Completed
370 enrolled
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡